784
Views
38
CrossRef citations to date
0
Altmetric
Reviews

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. 2008. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 57(7):1759–67.
  • Adamo A, Brandi J, Caligola S, Delfino P, Bazzoni R, Carusone R, Cecconi D, Giugno R, Manfredi M, Robotti E. 2019. Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell functions. Front Immunol. 10:446.
  • Admyre C, Johansson SM, Qazi KR, Filén -J-J, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S. 2007. Exosomes with immune modulatory features are present in human breast milk. J Immunol. 179:1969–78.
  • Bai L, Shao H, Wang H, Zhang Z, Su C, Dong L, Yu B, Chen X, Li X, Zhang X. 2017. Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Sci Rep. 7(1):4323.
  • Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. 2007. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 18(9):2486–96.
  • Blazquez R, Sanchez-Margallo FM, de la Rosa O, Dalemans W, Álvarez V, Tarazona R, Casado JG. 2014. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol. 5:556.
  • Bonab MM, Mohajeri M, Sahraian MA, Yazdanifar M, Aghsaie A, Farazmand A, Nikbin B. 2013. Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells. Arch Med Res. 44(4):266–72.
  • Breakefield XO, Frederickson RM, Simpson RJ. 2011. Gesicles: microvesicle “cookies” for transient information transfer between cells. Mol Ther. 19(9):1574–76.
  • Budoni M, Fierabracci A, Luciano R, Petrini S, Di Ciommo V, Muraca M. 2013. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant. 22(2):369–79.
  • Burrello J, Monticone S, Gai C, Gomez Y, Kholia S, Camussi G. 2016. Stem cell-derived extracellular vesicles and immune-modulation. Front Cell Dev Biol. 4:83.
  • Chandra S, Vimal D, Sharma D, Rai V, Gupta SC, Chowdhuri DK. 2017. Role of miRNAs in development and disease: lessons learnt from small organisms. Life Sci. 185:8–14.
  • Chen TS, Lai RC, Lee MM, Choo ABH, Lee CNLim SK. 2010. Mesenchymal stem cell secretes microparticles enriched in pre-micrornas. Nucleic Acids Res. 38(1):215–24.
  • Cohen JA, Imrey PB, Planchon SM, Bermel RA, Fisher E, Fox RJ, Bar-Or A, Sharp SL, Skaramagas TT, Jagodnik P. 2018. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Multiple Sclerosis J. 24(4):501–11.
  • Del Fattore A, Luciano R, Pascucci L, Goffredo BM, Giorda E, Scapaticci M, Fierabracci A, Muraca M. 2015a. Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T lymphocytes. Cell Transplant. 24(12):2615–27.
  • Del Fattore A, Luciano R, Saracino R, Battafarano G, Rizzo C, Pascucci L, Alessandri G, Pessina A, Perrotta A, Fierabracci A. 2015b. Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. Expert Opin Biol Ther. 15(4):495–504.
  • Deregibus M, Tetta C, Camussi G. 2010. The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. Histol Histopathol. 25(3):397–404.
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 8(4):315–17.
  • Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ. 2011. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomed Nanotechnol Biol Med. 7(6):780–88.
  • Drommelschmidt K, Serdar M, Bendix I, Herz J, Bertling F, Prager S, Keller M, Ludwig A-K, Duhan V, Radtke S. 2017. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun. 60:220–32.
  • Epelman S, Lavine KJ, Randolph GJ. 2014. Origin and functions of tissue macrophages. Immunity. 41(1):21–35.
  • Esmaili Gourvarchin Galeh H, Meysam Abtahi Froushani S, Afzale Ahangaran N, Hadai SN. 2018. Effects of educated monocytes with xenogeneic mesenchymal stem cell–derived conditioned medium in a mouse model of chronic asthma. Immunol Invest. 47(5):504–20.
  • Farinazzo A, Angiari S, Turano E, Bistaffa E, Dusi S, Ruggieri S, Bonafede R, Mariotti R, Constantin G, Bonetti B. 2018. Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis. Sci Rep. 8:7473.
  • Favaro E, Carpanetto A, Caorsi C, Giovarelli M, Angelini C, Cavallo-Perin P, Tetta C, Camussi G, Zanone MM. 2016. Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia. 59(2):325–33.
  • Ferreira R, Bernardino L. 2015. Dual role of microglia in health and disease: pushing the balance towards repair. Front Cell Neurosci. 9:51.
  • Fiore EJ, Mazzolini G, Aquino JB. 2015. Mesenchymal stem/stromal cells in liver fibrosis: recent findings, old/new caveats and future perspectives. Stem Cell Rev Rep. 11(4):586–97.
  • Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, Bruno S, Romagnoli R, Salizzoni M, Tetta C. 2012. Human liver stem cell‐derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells. 30(9):1985–98.
  • Gallina C, Turinetto V, Giachino C. 2015. A new paradigm in cardiac regeneration: the mesenchymal stem cell secretome. Stem Cells Int. 2015:1–10.
  • Grange C, Tapparo M, Bruno S, Chatterjee D, Quesenberry PJ, Tetta C, Camussi G. 2014. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med. 33(5):1055–63.
  • Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G. 2011. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71(15):5346–56.
  • Guo L, Lai P, Wang Y, Huang T, Chen X, Luo C, Geng S, Huang X, Wu S, Ling W. 2019. Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells. Int Immunopharmacol. 74:105663.
  • Hannafon BN, Ding W-Q. 2013. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 14(7):14240–69.
  • Hernanda PY, Pedroza-Gonzalez A, van der Laan LJ, Bröker ME, Hoogduijn MJ, Ijzermans JN, Bruno MJ, Janssen HL, Peppelenbosch MP, Pan Q. 2013. Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. Carcinogenesis. 34(10):2330–40.
  • Horwitz EM, Andreef M, Frassoni F. 2006. Mesenchymal stromal cells. Curr Opin Hematol. 13:419.
  • Huang B, Cheng X, Wang H, Huang W, Wang D, Zhang K, Zhang H, Xue Z, Da Y, Zhang N. 2016. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 14:45.
  • Hyun J, Wang S, Kim J, Kim GJ, Jung Y. 2015. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci Rep. 5(1):14135.
  • Ignowski JM, Schaffer DV. 2004. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng. 86:827–34.
  • Jang SC, Kim SR, Yoon YJ, Park KS, Kim JH, Lee J, Kim OY, Choi EJ, Kim DK, Choi DS. 2015. In vivo kinetic biodistribution of nano‐sized outer membrane vesicles derived from bacteria. Small. 11:456–61.
  • Jiang M, Wang H, Jin M, Yang X, Ji H, Jiang Y, Zhang H, Wu F, Wu G, Lai X. 2018. Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization. Cell Physiol Biochem. 47(2):864–78.
  • Kahlert C, Kalluri R. 2013. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med. 91(4):431–37.
  • Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A. 2014. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Bio Chem. 289(7):3869–75.
  • Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borràs FE, Breakefield X, Budnik V. 2012. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10(12):e1001450.
  • Kang D, Oh S, Ahn S-M, Lee B-H, Moon MH. 2008. Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography− tandem mass spectrometry. J Proteome Res. 7(8):3475–80.
  • Karp JM, Teo GSL. 2009. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 4(3):206–16.
  • Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M. 2013. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 335(1):201–04.
  • Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, Saijo Y. 2011. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 19(1):196–203.
  • Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y, Kuroda M, Ochiya T. 2013. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep. 3(1):1197.
  • Kelleher RJ, Balu-Iyer S, Loyall J, Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS, Wallace PK. 2015. Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade. Cancer Immunol Res. 3(11):1269–78.
  • Koc O, Lazarus H. 2001. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant. 27(3):235.
  • Kordelas L, Rebmann V, Ludwig A, Radtke S, Ruesing J, Doeppner T, Epple M, Horn P, Beelen D, Giebel B. 2014. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 28(4):970.
  • Kowal J, Tkach M, Théry C. 2014. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 29:116–25.
  • Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire CA, Chen JW, Tannous BA, Breakefield XO. 2014. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 8:483–94.
  • Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM. 2010. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4:214–22.
  • Lai RC, Chen TS, Lim SK. 2011. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 6(4):481–92.
  • Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, De Kleijn DP, Choo A, Lim SK. 2012. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012:1–14.
  • Lankford KL, Arroyo EJ, Nazimek K, Bryniarski K, Askenase PW, Kocsis JD, Sabaawy HE. 2018. Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord. PLoS One. 13(1):e0190358.
  • Laso-García F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, Feliú A, Gómez-de Frutos M, Mecha M, Díez-Tejedor E, Guaza C, Gutiérrez-Fernández M. 2018. Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis. PLoS One. 13(9):e0202590.
  • Lässer C, Eldh M, Lötvall J. 2012. Isolation and characterization of RNA-containing exosomes. JoVE. 59:e3037.
  • Lee J-K, Park S-R, Jung B-K, Jeon Y-K, Lee Y-S, Kim M-K, Kim Y-G, Jang J-Y, Kim C-W. 2013. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. 8:e84256.
  • Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W. 2012. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22:845–54.
  • Lin F, Moran A, Igarashi P. 2005. Intrarenal cells, not bone marrow–derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest. 115(7):1756–64.
  • Lopez-Verrilli M, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M. 2016. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience. 320:129–39.
  • Lou G, Chen Z, Zheng M, Liu Y. 2017. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 49(6):e346.
  • Mathivanan S, Ji H, Simpson RJ. 2010. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 73(10):1907–20.
  • Mendt M, Rezvani K, Shpall E. 2019. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant. 54(S2):789–92.
  • Mokarizadeh A., Delirezh N., Morshedi A., Mosayebi G., Farshid A. A., Mardani K. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunology letters. 147(1-2):47–54.
  • Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N. 2004. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 15:1794–804.
  • Müller N, Weidinger E, Leitner B, Schwarz MJ. 2015. The role of inflammation in schizophrenia. Front Neurosci. 9:372.
  • Nakamura Y, Miyaki S, Ishitobi H, Matsuyama S, Nakasa T, Kamei N, Akimoto T, Higashi Y, Ochi M. 2015. Mesenchymal‐stem‐cell‐derived exosomes accelerate skeletal muscle regeneration. FEBS Lett. 589(11):1257–65.
  • Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T, Kotb E, Temraz M, Saad A-N, Essa W, Adel H. 2016. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res. 20(1):21.
  • Niapour N, Taghipour Z, Salehi H, Bagheri A, Rouhani A, Talebi M, Najafzadeh N, Niapour A. 2015. Isolation and identification of mesenchymal and neural crest characteristics of dental pulp derived stem cells. Koomesh. 16(4).
  • Ohno S-I, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T. 2013. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 21(1):185–91.
  • Okkenhaug K. 2013. Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity. Ann N Y Acad Sci. 1280(1):24.
  • Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi R-U, Yoshida M, Tsuda H, Tamura K, Ochiya T. 2014. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal. 7:ra63–ra63.
  • Porada CD, Almeida-Porada G. 2010. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev. 62(12):1156–66.
  • Record M, Subra C, Silvente-Poirot S, Poirot M. 2011. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol. 81(10):1171–82.
  • Reiner AT, Witwer KW, Van Balkom BW, De Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, De Kleijn D. 2017. Concise review: developing best‐practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 6(8):1730–39.
  • Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N, Camussi G. 2012. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One. 7(9):e44092.
  • Reis M, Mavin E, Nicholson L, Green K, Dickinson AM, Wang X-N. 2018. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol. 9:2538.
  • Roccaro AM, Sacco A, Maiso P, Azab AK, Tai Y-T, Reagan M, Azab F, Flores LM, Campigotto F, Weller E. 2013. BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression. J Clin Invest. 123(4):1542–55.
  • Sahraian MA, Mohyeddin Bonab M, Baghbanian SM, Owji M, Naser Moghadasi A. 2019. Therapeutic use of intrathecal mesenchymal stem cells in patients with multiple sclerosis: a pilot study with booster injection. Immunol Invest. 48(2):160–68.
  • Sarvar DP, Shamsasenjan K, Akbarzadehlaleh P. 2016. Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy. Adv Pharm Bull. 6(3):293.
  • Sato T, Iso Y, Uyama T, Kawachi K, Wakabayashi K, Omori Y, Soda T, Shoji M, Koba S, Yokoyama S-I. 2011. Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest. 91(4):553.
  • Shen B, Liu J, Zhang F, Wang Y, Qin Y, Zhou Z, Qiu J, Fan Y. 2016. CCR2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia/reperfusion-induced renal injury. Stem Cells Int. 2016:1–9.
  • Shenoy GN, Loyall J, Berenson CS, Kelleher RJ, Iyer V, Balu-Iyer SV, Odunsi K, Bankert RB. 2018. Sialic acid–dependent inhibition of t cells by exosomal ganglioside GD3 in ovarian tumor microenvironments. J Immunol. 201(12):3750–58.
  • Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. 2012. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 33(3):136–43.
  • Shimbo K, Miyaki S, Ishitobi H, Kato Y, Kubo T, Shimose S, Ochi M. 2014. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 445(2):381–87.
  • Sicco CL, Reverberi D, Balbi C, Ulivi V, Principi E, Pascucci L, Becherini P, Bosco MC, Varesio L, Franzin C. 2017. Mesenchymal stem cell‐derived extracellular vesicles as mediators of anti‐inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med. 6(3):1018–28.
  • Smirnov SV, Harbacheuski R, Lewis-Antes A, Zhu H, Rameshwar P, Kotenko SV. 2007. Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology. 360(1):6–16.
  • Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. 2015. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Controlled Release. 199:145–55.
  • Sokolova V, Ludwig A-K, Hornung S, Rotan O, Horn PA, Epple M, Giebel B. 2011. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B. 87(1):146–50.
  • Song J-Y, Kang HJ, Hong JS, Kim CJ, Shim J-Y, Lee CW, Choi J. 2017. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 7(1):9412.
  • Song W, Liu C, Upadhyaya A. 2014. The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation. Biochim Biophys Acta Biomembr. 1838(2):569–78.
  • Spinosa M, Lu G, Su G, Bontha SV, Gehrau R, Salmon MD, Smith JR, Weiss ML, Mas VR, Upchurch GR Jr. 2018. Human mesenchymal stromal cell–derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147. Faseb J. 32(11):6038–50.
  • Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, De Medina P, Monsarrat B, Perret B, Silvente-Poirot S. 2010. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res. 51(8):2105–20.
  • Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y. 2013. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 165(2):77–84.
  • Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP. 2015. Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 12(8):445–64.
  • Tamura R, Uemoto S, Tabata Y. 2016. Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflamm Regen. 36(1):26.
  • Tan CY, Lai RC, Wong W, Dan YY, Lim S-K, Ho HK. 2014. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 5(3):76.
  • Théry C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2(8):569.
  • Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, Zhao Y, Liu H, Fu X, Han W. 2015. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 13(1):308.
  • Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G. 2014. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 35(7):2383–90.
  • Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN. 2008. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1(2):129–37.
  • Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. 2009. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res. 104(3):398–402.
  • van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R, Mattson MP. 2012. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 64(3):676–705.
  • Wang R, Lin M, Zhu T. 2014. Bone marrow mesenchymal stem cell-derived exosome protects kidney against ischemia reperfusion injury in rats. Zhonghua Yi Xue Za Zhi. 94(42):3298–303.
  • Wen D, Peng Y, Liu D, Weizmann Y, Mahato RI. 2016. Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation. J Controlled Release. 238:166–75.
  • Wickman G, Julian L, Olson M. 2012. How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ. 19(5):735.
  • Wiklander OP, Nordin JZ, O’Loughlin A, Gustafsson Y, Corso G, Mäger I, Vader P, Lee Y, Sork H, Seow Y. 2015. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracellular Vesicles. 4(1):26316.
  • Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, Kwong A, Mitsialis SA, Kourembanas S. 2018. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am J Respir Crit Care Med. 197:104–16.
  • Wolfson B, Eades G, Zhou Q. 2014. Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells. 6(5):591.
  • Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, Shang X, Zhang ZG, Chopp M. 2012. Exosome‐mediated transfer of miR‐133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 30(7):1556–64.
  • Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. 2013. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metabol. 33(11):1711–15.
  • Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R. 2010. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 227(1–2):185–89.
  • Yang Y, Bucan V, Baehre H, Von der Ohe J, Otte A, Hass R. 2015. Acquisition of new tumor cell properties by MSC-derived exosomes. Int J Oncol. 47:244–52.
  • Yin K, Wang S, Zhao RC. 2019. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomarker Res. 7(1):8.
  • Yoon YJ, Kim OY, Gho YS. 2014. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep. 47:531.
  • Zare N, Eskandari N, Mehrzad V, Javanmard S. 2019a. The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma. J Res Med Sci. 24(1):10.
  • Zare, N., Haghjooy Javanmard, S., Mehrzad, V., Eskandari, N., Kefayat, A. 2019b. Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP. Leukemia & lymphoma. 60(8):1877–1889.
  • Zeringer E, Barta T, Li M, Vlassov AV. 2015. Strategies for isolation of exosomes. Cold Spring Harbor Protoc. 2015(4). pdb. top074476. doi:10.1101/pdb.top074476.
  • Zhang B, Yeo RWY, Lai RC, Sim EWK, Chin KC, Lim SK. 2018. Mesenchymal stromal cell exosome–enhanced regulatory T-cell production through an antigen-presenting cell–mediated pathway. Cytotherapy. 20(5):687–96.
  • Zhang B, Yin Y, Lai RC, Tan SS, Choo ABH, Lim SK. 2013. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 23(11):1233–44.
  • Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, Xiong Y. 2015. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 122(4):856–67.
  • Zhao H, Shang Q, Pan Z, Bai Y, Li Z, Zhang H, Zhang Q, Guo C, Zhang L, Wang Q. 2018. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes. 67(2):235–47.
  • Zhu W, Huang L, Li Y, Qian H, Shan X, Yan Y, Mao F, Wu X, Xu W-R. 2011. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle. 10(18):3198–207.
  • Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W. 2012. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 315(1):28–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.